San Francisco, 04 March , Stem
Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent
Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By
Technology, By Therapy, And Segment Forecasts, 2018 - 2025
The global stem cell market is
expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%,
according to a new report by Grand View Research, Inc. Augmentation in research
studies that aim at broadening the utility scope of associated products is
anticipated to drive the market growth. These research projects have opened the
possibility of implementation of several clinical applications of these cells,
thereby impacting disease-modifying treatments.
Scientists are engaged in discovering novel methods to
create human stem cells. This is to address the increasing demand for stem cell
production for potential investigation in disease management. This factor is
certainly expected to accelerate the development of regenerative medicine, thus
driving industrial growth.
Moreover, cellular therapies are recognized as the next
major advancements in transforming healthcare. Firms are expanding their
cellular therapy portfolio, understanding the future potential of this arena in
the treatment of Parkinson's disease, type 1 diabetes, spinal cord injury,
Alzheimer's disease, and others.
In March 2016, Scientists at Michigan State University
unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This
discovery is expected to drive advancements in regenerative medicine. Such
discoveries are anticipated to bolster research and sales in this market over
the forecast period.
Access Full Research
Report On Stem
Cells Market Analysis:
Further key findings from the report
suggest:
·
Adult stem cells dominated the market and
is expected to maintain its dominance. This can be attributed to the several
factors such as lower rejection rates, long term renewal property, and no
ethical concerns associated with their usage
·
Application wise regenerative medicine is
estimated to hold the substantial share of the revenue
·
Presence of significant number pipeline
projects for regenerative medicine is expected to fuel growth in the market
·
In addition, exploding research projects
have driven the need of harvesting techniques, thereby propelling progress of
acquisition technology
·
Increased R&D activities and huge funds
granted by funding bodies to advance cellular research in the U.S. have resulted
into the large share of North America
·
Extensive research carried out in Singapore
and Japan is anticipated to drive progress with lucrative avenues
·
Advanced Cell Technology Inc, Osiris
Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL
Technologies Inc., are some of the major companies operating in this market
·
A number of companies are engaged in
seeking investment from overseas organizations and also developing partnerships
with the pharmaceutical organizations
Browse More
Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global stem cells
market on the basis of product, application, technology, therapy, and region:
Stem Cell Product Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Adult Stem Cells
o
Neuronal Stem Cells
o
Hematopoietic Stem Cells
o
Mesenchymal Stem Cells
o
Umbilical Cord Stem Cells
o
Others
·
Human Embryonic Stem Cells
·
Induced Pluripotent Stem Cells
·
Very Small Embryonic Like Stem Cells
Stem Cell Application Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Regenerative Medicine
o
Neurology
o
Orthopedics
o
Oncology
o
Hematology
o
Cardiovascular and Myocardial Infraction
o
Injuries
o
Diabetes
o
Liver Disorder
o
Incontinence
o
Others
·
Drug Discovery and Development
Stem Cell Technology Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Cell Acquisition
o
Bone Marrow Harvest
o
Umbilical Blood Cord
o
Apheresis
·
Cell Production
o
Therapeutic Cloning
o
In-vitro Fertilization
o
Cell Culture
o
Isolation
·
Cryopreservation
·
Expansion and Sub-Culture
Stem Cell Therapy Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Autologous Stem Cell Therapy
·
Allogeneic Stem Cell Therapy
Stem Cell Regional Outlook (Revenue, USD
Billion, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
Middle East & Africa
o
South Africa
Browse Press
Release of this Report:
https://www.grandviewresearch.com/press-release/global-stem-cells-market
https://www.grandviewresearch.com/press-release/global-stem-cells-market
About Grand View
Research
Grand View
Research provides syndicated as well as customized research reports and
consulting services on 46 industries across 25 major countries worldwide. This
U.S.-based market research and consulting company is registered in California
and headquartered in San Francisco. Comprising over 425 analysts and
consultants, the company adds 1200+ market research reports to its extensive
database each year. Supported by an interactive market intelligence platform,
the team at Grand View Research guides Fortune 500 companies and prominent
academic institutes in comprehending the global and regional business
environment and carefully identifying future opportunities.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment